Drug addiction is a chronic and complex brain disease, adding much burden on the community. Though numerous efforts have been made to identify the effective treatment, it is necessary to find more novel therapeutics for this complex disease. As network pharmacology has become a promising approach for drug repurposing, we proposed to apply the approach to drug addiction, which might provide new clues for the development of effective addiction treatment drugs. We first extracted 44 addictive drugs from the NIDA and their targets from DrugBank. Then, we constructed two networks: an addictive drug-target network and an expanded addictive drug-target network by adding other drugs that have at least one common target with these addictive drugs. B...
The growing number and variety of genetic network datasets increases the feasibility of understandin...
Analyzing different drugs for various purposes is an important issue in the area of computational bi...
<div><p>Drugs with similar side-effect profiles may share similar therapeutic properties through rel...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
The available data of drugs and their targets has increased widely in recent years. Far from the tra...
Despite advances in pharmacology and neuroscience, the path to new medications for psychiatric disor...
Mining potential drug-disease associations can speed up drug repositioning for pharmaceutical compan...
Recent research trends in computer-aided drug design have shown an increasing interest towards the i...
Drugs with similar side-effect profiles may share similar therapeutic properties through related mec...
A bottleneck in drug discovery is the identification of the molecular targets of a compound (mode of...
The increasing cost of drug development together with a significant drop in the number of new drug a...
Background: Combination of different agents is widely used in clinic to combat complex diseases with...
The mechanisms underlying drug addiction remain nebulous. Furthermore, new psychoactive substances (...
<div><p>The growing number and variety of genetic network datasets increases the feasibility of unde...
A bottleneck in drug discovery is the identification of the molecular targets of a compound (mode of...
The growing number and variety of genetic network datasets increases the feasibility of understandin...
Analyzing different drugs for various purposes is an important issue in the area of computational bi...
<div><p>Drugs with similar side-effect profiles may share similar therapeutic properties through rel...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
The available data of drugs and their targets has increased widely in recent years. Far from the tra...
Despite advances in pharmacology and neuroscience, the path to new medications for psychiatric disor...
Mining potential drug-disease associations can speed up drug repositioning for pharmaceutical compan...
Recent research trends in computer-aided drug design have shown an increasing interest towards the i...
Drugs with similar side-effect profiles may share similar therapeutic properties through related mec...
A bottleneck in drug discovery is the identification of the molecular targets of a compound (mode of...
The increasing cost of drug development together with a significant drop in the number of new drug a...
Background: Combination of different agents is widely used in clinic to combat complex diseases with...
The mechanisms underlying drug addiction remain nebulous. Furthermore, new psychoactive substances (...
<div><p>The growing number and variety of genetic network datasets increases the feasibility of unde...
A bottleneck in drug discovery is the identification of the molecular targets of a compound (mode of...
The growing number and variety of genetic network datasets increases the feasibility of understandin...
Analyzing different drugs for various purposes is an important issue in the area of computational bi...
<div><p>Drugs with similar side-effect profiles may share similar therapeutic properties through rel...